State of New Jersey Common Pension Fund D’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-45,897
Closed -$1.88M 1564
2024
Q2
$1.88M Sell
45,897
-21,973
-32% -$915K 0.01% 1199
2024
Q1
$2.87M Buy
+67,870
New +$2.85M 0.01% 1274
2023
Q3
Sell
-73,492
Closed -$2.34M 1674
2023
Q2
$2.34M Buy
+73,492
New +$2.26M 0.01% 1480
2023
Q1
Sell
-79,963
Closed -$2.52M 1761
2022
Q4
$2.52M Buy
79,963
+4,394
+6% +$124K 0.01% 992
2022
Q3
$2.14M Buy
+75,569
New +$2.25M 0.01% 1214

Other funds holding CERE

State of New Jersey Common Pension Fund D's CERE Position: Q3 2024 in Review

State of New Jersey Common Pension Fund D sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 45,897 shares — an estimated $1.88M sold.

State of New Jersey Common Pension Fund D first reported a position in CERE in Q3 2022 and held it in 5 quarters. The position peaked at $2.87M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • State of New Jersey Common Pension Fund D reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 45,897 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.88M.
  • State of New Jersey Common Pension Fund D first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • State of New Jersey Common Pension Fund D's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.87M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2024, filed 4 Nov 2024.